Cargando…
Effect of levosimendan combined with recombinant human brain natriuretic peptide on diuretic resistance
Levosimendan is a calcium sensitizer used for managing heart failure (HF) because of its inotropic and vasodilatory effects. As many patients do not respond to levosimendan as a monotherapy, it may be necessary to combine it with other diuretic agents such as recombinant human brain natriuretic pept...
Autores principales: | Xiangli, Shen, Lan, Li, Libiya, Zu, Jun, Ma, Shubin, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439246/ https://www.ncbi.nlm.nih.gov/pubmed/34493175 http://dx.doi.org/10.1080/19932820.2021.1973762 |
Ejemplares similares
-
Diuretic and natriuretic activity of two mistletoe species in rats
por: Jadhav, Namita, et al.
Publicado: (2010) -
Effects of levosimendan/furosemide infusion on Plasma Brain Natriuretic Peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients
por: Feola, Mauro, et al.
Publicado: (2011) -
Neuroendocrine hormone status and diuretic response to atrial natriuretic peptide in patients with acute heart failure
por: Matsumoto, Shingo, et al.
Publicado: (2022) -
The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
por: Michalopoulou, H, et al.
Publicado: (2007) -
The influence of aldosterone and angiotensin II on the diuretic effects of atrial natriuretic peptide in the isolated perfused rat kidney
por: Heringlake, M, et al.
Publicado: (1999)